论文部分内容阅读
原发性肝癌(简称肝癌)常见于亚非地区,近年来其发病率在世界范围内有明显增高的趋势.肝癌发病隐匿、发展快、预后不佳.随着AFP和各项显像技术广泛应用,发现了不少小肝癌病例,使肝癌手术进入了亚临床水平,目前几无手术死亡.小肝癌术后五年生存率达70.5%.尽管目前手术切除是最好的治疗方法,但同其它实体肿瘤治疗相比还有相当差距.近年从不同学科的角度对影响肝癌预后的可能因素进行了大量研究,现仅就几个主要的方面作一综述.临床与肝癌生存有关的因素
Primary liver cancer (abbreviated as hepatocellular carcinoma) is common in Asia and Africa, and its incidence in the world has increased significantly in recent years. Hepatocarcinogenesis is obscure, rapid development, and poor prognosis. With AFP and various imaging techniques In the application, many cases of small hepatocellular carcinoma were discovered, and the operation of liver cancer entered a subclinical level. At present, there are few operative deaths. The five-year survival rate of small hepatocellular carcinoma is 70.5%. Although the current surgical resection is the best treatment method, the same There is still a considerable gap between the treatment of other solid tumors. In recent years, a large number of studies have been conducted on the probable factors affecting the prognosis of liver cancer from a variety of disciplines. There are only a few major areas for review. Clinical and liver cancer-related factors